Francesc Cabré

1.1k total citations
55 papers, 995 citations indexed

About

Francesc Cabré is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Francesc Cabré has authored 55 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 14 papers in Molecular Biology and 14 papers in Pharmacology. Recurrent topics in Francesc Cabré's work include Inflammatory mediators and NSAID effects (15 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Analytical Chemistry and Chromatography (7 papers). Francesc Cabré is often cited by papers focused on Inflammatory mediators and NSAID effects (15 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Analytical Chemistry and Chromatography (7 papers). Francesc Cabré collaborates with scholars based in Spain, Mexico and Italy. Francesc Cabré's co-authors include David Mauleón, Albert Palomer, Assumpta Carabaza, Jaume Pascual, Enric I. Canela, Germano Carganico, Miguel Á. Gallo, María A. Trujillo, Antonio Entrena and Joaquín M. Campos Rosa and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Biochemical Pharmacology.

In The Last Decade

Francesc Cabré

54 papers receiving 924 citations

Peers

Francesc Cabré
Mark C. Walker United States
Earl G. Burton United States
Timothy J. Maziasz United States
Timothy W. Harper United States
Carmela Gnerre Switzerland
James R. Tata United States
Alex J. Vecchio United States
Mark C. Walker United States
Francesc Cabré
Citations per year, relative to Francesc Cabré Francesc Cabré (= 1×) peers Mark C. Walker

Countries citing papers authored by Francesc Cabré

Since Specialization
Citations

This map shows the geographic impact of Francesc Cabré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesc Cabré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesc Cabré more than expected).

Fields of papers citing papers by Francesc Cabré

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesc Cabré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesc Cabré. The network helps show where Francesc Cabré may publish in the future.

Co-authorship network of co-authors of Francesc Cabré

This figure shows the co-authorship network connecting the top 25 collaborators of Francesc Cabré. A scholar is included among the top collaborators of Francesc Cabré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesc Cabré. Francesc Cabré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabré, Francesc, et al.. (2023). Review of Topical Sodium Heparin 1000 IU/g Gel in Symptomatic Uncomplicated Superficial Thrombophlebitis. Cureus. 15(10). e47418–e47418. 2 indexed citations
2.
Palomer, Albert, Jaume Pascual, Mònica Aparici, et al.. (2002). Structure-Based Design of Cyclooxygenase-2 Selectivity into Ketoprofen. Bioorganic & Medicinal Chemistry Letters. 12(4). 533–537. 48 indexed citations
3.
Alarcón‐de‐la‐Lastra, Catalina, et al.. (2002). Gastric toxicity of racemic ketoprofen and its enantiomers in rat: Oxygen radical generation and COX-expression. Inflammation Research. 51(2). 51–57. 25 indexed citations
4.
Cabré, Francesc, Assumpta Carabaza, Ana Maria Garcı́a, et al.. (2002). Pharmacological profile of MEN91507, a new CysLT1 receptor antagonist. European Journal of Pharmacology. 451(3). 317–326. 6 indexed citations
5.
Nieto, Ana, Francesc Cabré, Francisco J. Moreno, & Catalina Alarcón‐de‐la‐Lastra. (2002). Mechanisms involved in the attenuation of intestinal toxicity induced by (S)-(+)-ketoprofen in re-fed rats.. Digestive Diseases and Sciences. 47(4). 905–913. 3 indexed citations
6.
Holzer, Peter, et al.. (2001). Estimation of acute flurbiprofen and ketoprofen toxicity in rat gastric mucosa at therapy-relevant doses. Inflammation Research. 50(12). 602–608. 11 indexed citations
7.
López‐Muñoz, Francisco Javier, et al.. (2000). Analysis of antinociceptive effects of flurbiprofen enantiomers ina rat model of arthritic pain. Methods and Findings in Experimental and Clinical Pharmacology. 22(8). 641–641. 4 indexed citations
8.
Nieto, Ana, et al.. (2000). Intestinal toxicity of ketoprofen-trometamol vs its enantiomers in rat. Role of oxidative stress. Inflammation Research. 49(11). 627–632. 27 indexed citations
9.
Cabré, Francesc, et al.. (1998). Intestinal Ulcerogenic Effect of S(+)‐Ketoprofen in the Rat. The Journal of Clinical Pharmacology. 38(S1). 27S–32S. 12 indexed citations
10.
Íñiguez, Miguel A., José L. Pablos, Patrícia Carreira, Francesc Cabré, & Juan J. Gómez‐Reino. (1998). Detection of COX-1 and COX-2 isoforms in synovial fluid cells from inflammatory joint diseases. Lara D. Veeken. 37(7). 773–778. 36 indexed citations
11.
López‐Muñoz, Francisco Javier, et al.. (1998). Antinociceptive Effects of S(+)‐Ketoprofen and Other Analgesic Drugs in a Rat Model of Pain Induced Uric Acid. The Journal of Clinical Pharmacology. 38(S1). 11S–21S. 16 indexed citations
12.
Cabré, Francesc, et al.. (1993). Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists. Inflammation Research. 38(1-2). 212–219. 29 indexed citations
13.
Cabré, Francesc, et al.. (1992). Antiflammins. Biochemical Pharmacology. 44(3). 519–525. 30 indexed citations
14.
Cabré, Francesc, Marta Cascante, & Enric I. Canela. (1992). The molybdoenzymes xanthine oxidase and aldehyde oxidase contain fast- and slow-DTNB reacting sulphydryl groups. Journal of Protein Chemistry. 11(5). 547–551. 2 indexed citations
15.
Cabré, Francesc, et al.. (1992). Differential hydrolysis of 1-alkyl-2-acyl and diacylglycerophosphocholines by human and non-human phospholipases A2. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1124(3). 297–299. 3 indexed citations
16.
Cabré, Francesc, Marta Cascante, & Enric I. Canela. (1991). An Improved Purification Procedure for Sulfite Oxidase from Bovine Liver. Preparative Biochemistry. 21(1). 53–61. 2 indexed citations
17.
Cabré, Francesc, et al.. (1990). Purification of Adenosine Deaminase from Chicken-Egg Yolk by Affinity Column Chromatography. Preparative Biochemistry. 20(3-4). 199–204. 3 indexed citations
18.
Cabré, Francesc, et al.. (1990). Occurrence and comparison of sulfite oxidase activity in mammalian tissues. Biochemical Medicine and Metabolic Biology. 43(2). 159–162. 32 indexed citations
19.
Cabré, Francesc, Enric I. Canela, & Miguel Ángel Canela. (1989). Accuracy and precision in the determination of stokes radii and molecular masses of proteins by gel filtration chromatography. Journal of Chromatography A. 472(2). 347–356. 23 indexed citations
20.
Cabré, Francesc, et al.. (1988). Identification and rejection of outliers in enzyme kinetics. International Journal of Bio-Medical Computing. 23(1-2). 9–20. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026